Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lassa Fever | 31 | 2024 | 97 | 8.250 |
Why?
|
Antimalarials | 61 | 2023 | 908 | 7.220 |
Why?
|
Malaria, Falciparum | 56 | 2023 | 1075 | 6.820 |
Why?
|
Artemisinins | 38 | 2022 | 217 | 6.640 |
Why?
|
Nigeria | 81 | 2024 | 779 | 6.010 |
Why?
|
Lassa virus | 27 | 2024 | 99 | 5.920 |
Why?
|
Amodiaquine | 32 | 2023 | 58 | 5.360 |
Why?
|
Plasmodium falciparum | 42 | 2022 | 1741 | 4.460 |
Why?
|
Drug Resistance | 21 | 2022 | 1595 | 2.340 |
Why?
|
Fluorenes | 18 | 2023 | 160 | 2.290 |
Why?
|
Ethanolamines | 18 | 2023 | 153 | 2.130 |
Why?
|
Ebolavirus | 13 | 2020 | 250 | 2.010 |
Why?
|
Protozoan Proteins | 12 | 2022 | 844 | 1.990 |
Why?
|
Genome, Viral | 11 | 2024 | 673 | 1.890 |
Why?
|
Parasitemia | 19 | 2019 | 165 | 1.800 |
Why?
|
Chiroptera | 2 | 2024 | 62 | 1.730 |
Why?
|
Hemorrhagic Fever, Ebola | 14 | 2020 | 424 | 1.700 |
Why?
|
Disease Outbreaks | 16 | 2022 | 1762 | 1.300 |
Why?
|
Monkeypox virus | 3 | 2023 | 43 | 1.010 |
Why?
|
Anemia | 14 | 2019 | 1519 | 1.010 |
Why?
|
Dihydropteroate Synthase | 2 | 2021 | 27 | 0.990 |
Why?
|
Chloroquine | 9 | 2015 | 275 | 0.990 |
Why?
|
Drug Combinations | 30 | 2023 | 2079 | 0.970 |
Why?
|
RNA, Viral | 9 | 2023 | 2866 | 0.960 |
Why?
|
Tetrahydrofolate Dehydrogenase | 2 | 2021 | 133 | 0.950 |
Why?
|
Multidrug Resistance-Associated Proteins | 4 | 2020 | 105 | 0.950 |
Why?
|
Antigens, Viral | 9 | 2020 | 992 | 0.900 |
Why?
|
Genomics | 14 | 2024 | 5916 | 0.900 |
Why?
|
Malaria | 10 | 2024 | 1241 | 0.890 |
Why?
|
Phylogeny | 12 | 2024 | 2843 | 0.870 |
Why?
|
Nucleoproteins | 3 | 2020 | 110 | 0.860 |
Why?
|
RNA Viruses | 2 | 2022 | 111 | 0.850 |
Why?
|
Insect Viruses | 1 | 2022 | 15 | 0.820 |
Why?
|
Arboviruses | 1 | 2022 | 13 | 0.810 |
Why?
|
Polymorphism, Genetic | 8 | 2021 | 4250 | 0.780 |
Why?
|
Dengue Virus | 1 | 2024 | 204 | 0.780 |
Why?
|
Hemorrhagic Disease Virus, Rabbit | 1 | 2021 | 2 | 0.770 |
Why?
|
Abattoirs | 1 | 2021 | 6 | 0.770 |
Why?
|
Caliciviridae Infections | 1 | 2021 | 29 | 0.760 |
Why?
|
Shiga-Toxigenic Escherichia coli | 1 | 2021 | 26 | 0.750 |
Why?
|
Pyrimethamine | 7 | 2021 | 94 | 0.750 |
Why?
|
Food Microbiology | 1 | 2021 | 74 | 0.750 |
Why?
|
Aedes | 1 | 2022 | 101 | 0.740 |
Why?
|
Coronavirus | 1 | 2023 | 156 | 0.730 |
Why?
|
Extensively Drug-Resistant Tuberculosis | 1 | 2021 | 86 | 0.720 |
Why?
|
Antibodies, Viral | 11 | 2020 | 3211 | 0.720 |
Why?
|
HIV Integrase | 1 | 2022 | 122 | 0.720 |
Why?
|
Dengue | 1 | 2024 | 258 | 0.710 |
Why?
|
Membrane Transport Proteins | 6 | 2020 | 1034 | 0.710 |
Why?
|
Sulfadoxine | 5 | 2021 | 46 | 0.690 |
Why?
|
Food Contamination | 1 | 2021 | 193 | 0.680 |
Why?
|
HIV Integrase Inhibitors | 1 | 2022 | 165 | 0.670 |
Why?
|
Viruses | 1 | 2023 | 373 | 0.660 |
Why?
|
Yellow Fever | 1 | 2020 | 54 | 0.660 |
Why?
|
Metagenome | 2 | 2020 | 465 | 0.640 |
Why?
|
Microsatellite Repeats | 1 | 2021 | 784 | 0.630 |
Why?
|
Epidemics | 2 | 2022 | 517 | 0.610 |
Why?
|
Computer Systems | 1 | 2020 | 470 | 0.610 |
Why?
|
Meat | 1 | 2021 | 588 | 0.600 |
Why?
|
Africa, Western | 10 | 2023 | 160 | 0.600 |
Why?
|
Genes, MDR | 2 | 2008 | 36 | 0.590 |
Why?
|
Africa | 9 | 2024 | 726 | 0.590 |
Why?
|
Child, Preschool | 55 | 2021 | 42650 | 0.580 |
Why?
|
Zoonoses | 5 | 2023 | 180 | 0.560 |
Why?
|
Sex Ratio | 7 | 2011 | 107 | 0.540 |
Why?
|
Infant | 44 | 2021 | 36510 | 0.510 |
Why?
|
Rhabdoviridae | 1 | 2015 | 5 | 0.500 |
Why?
|
Rhabdoviridae Infections | 1 | 2015 | 9 | 0.500 |
Why?
|
Disaster Planning | 1 | 2021 | 560 | 0.490 |
Why?
|
Hematocrit | 10 | 2019 | 625 | 0.490 |
Why?
|
Staphylococcal Infections | 1 | 2024 | 1398 | 0.480 |
Why?
|
Rabbits | 1 | 2021 | 4781 | 0.480 |
Why?
|
Polymerase Chain Reaction | 10 | 2021 | 6085 | 0.460 |
Why?
|
Child | 56 | 2023 | 80891 | 0.460 |
Why?
|
Humans | 140 | 2024 | 768393 | 0.450 |
Why?
|
Haplotypes | 7 | 2021 | 2724 | 0.450 |
Why?
|
Hepatitis B | 3 | 2023 | 708 | 0.440 |
Why?
|
Metagenomics | 3 | 2023 | 475 | 0.430 |
Why?
|
Genetic Variation | 10 | 2021 | 6606 | 0.420 |
Why?
|
Drug Therapy, Combination | 22 | 2021 | 6318 | 0.380 |
Why?
|
Pandemics | 9 | 2024 | 8753 | 0.380 |
Why?
|
DNA, Protozoan | 5 | 2012 | 228 | 0.360 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2022 | 16028 | 0.350 |
Why?
|
Mycobacterium tuberculosis | 1 | 2021 | 1929 | 0.350 |
Why?
|
Animals | 46 | 2024 | 169337 | 0.340 |
Why?
|
Mutation, Missense | 2 | 2011 | 2593 | 0.340 |
Why?
|
Selection, Genetic | 4 | 2014 | 877 | 0.330 |
Why?
|
Linkage Disequilibrium | 3 | 2021 | 1998 | 0.330 |
Why?
|
Hepatitis B, Chronic | 2 | 2023 | 413 | 0.320 |
Why?
|
Mefloquine | 5 | 2012 | 55 | 0.320 |
Why?
|
Coronavirus Infections | 3 | 2023 | 3118 | 0.310 |
Why?
|
Plasmodium berghei | 3 | 2015 | 161 | 0.310 |
Why?
|
Antigens, Protozoan | 4 | 2021 | 315 | 0.310 |
Why?
|
Merozoite Surface Protein 1 | 3 | 2021 | 36 | 0.290 |
Why?
|
Genome, Bacterial | 2 | 2024 | 796 | 0.290 |
Why?
|
Antibodies, Neutralizing | 3 | 2024 | 2006 | 0.280 |
Why?
|
Proguanil | 1 | 2006 | 11 | 0.280 |
Why?
|
Seroepidemiologic Studies | 3 | 2024 | 405 | 0.280 |
Why?
|
Male | 66 | 2023 | 364902 | 0.270 |
Why?
|
Cytochromes b | 1 | 2006 | 35 | 0.270 |
Why?
|
Female | 64 | 2024 | 397089 | 0.270 |
Why?
|
Naphthoquinones | 1 | 2006 | 59 | 0.270 |
Why?
|
Sierra Leone | 8 | 2020 | 171 | 0.270 |
Why?
|
Parasitic Sensitivity Tests | 3 | 2012 | 90 | 0.270 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2020 | 827 | 0.260 |
Why?
|
N-Acetylglucosaminyltransferases | 2 | 2021 | 167 | 0.260 |
Why?
|
Communicable Diseases | 1 | 2014 | 873 | 0.260 |
Why?
|
Rifampin | 2 | 2021 | 345 | 0.260 |
Why?
|
Microbial Sensitivity Tests | 2 | 2024 | 1961 | 0.260 |
Why?
|
Sequence Analysis, DNA | 8 | 2021 | 4775 | 0.260 |
Why?
|
Enzyme-Linked Immunospot Assay | 2 | 2024 | 126 | 0.260 |
Why?
|
Genotype | 8 | 2023 | 13042 | 0.250 |
Why?
|
Hepatitis B virus | 3 | 2023 | 530 | 0.250 |
Why?
|
Murinae | 2 | 2022 | 18 | 0.240 |
Why?
|
Hemorrhagic Fevers, Viral | 2 | 2016 | 23 | 0.240 |
Why?
|
Point Mutation | 2 | 2006 | 1594 | 0.230 |
Why?
|
HIV-1 | 1 | 2022 | 6963 | 0.230 |
Why?
|
Molecular Diagnostic Techniques | 3 | 2020 | 620 | 0.230 |
Why?
|
Communicable Diseases, Emerging | 2 | 2018 | 148 | 0.230 |
Why?
|
Multilocus Sequence Typing | 1 | 2024 | 102 | 0.230 |
Why?
|
Endemic Diseases | 3 | 2017 | 190 | 0.220 |
Why?
|
Cross Reactions | 3 | 2020 | 828 | 0.220 |
Why?
|
Animals, Domestic | 1 | 2023 | 56 | 0.220 |
Why?
|
Area Under Curve | 6 | 2017 | 1642 | 0.220 |
Why?
|
Swine | 2 | 2024 | 5994 | 0.220 |
Why?
|
Goats | 1 | 2023 | 166 | 0.210 |
Why?
|
Evolution, Molecular | 4 | 2024 | 1893 | 0.210 |
Why?
|
Immunoglobulin G | 4 | 2024 | 4570 | 0.210 |
Why?
|
Disease Reservoirs | 3 | 2018 | 123 | 0.210 |
Why?
|
Saliva | 3 | 2013 | 854 | 0.210 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2004 | 239 | 0.200 |
Why?
|
Amino Acid Substitution | 1 | 2006 | 1742 | 0.200 |
Why?
|
Capreomycin | 1 | 2021 | 14 | 0.200 |
Why?
|
Adolescent | 23 | 2021 | 89184 | 0.190 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2021 | 3666 | 0.190 |
Why?
|
Democratic Republic of the Congo | 2 | 2019 | 87 | 0.190 |
Why?
|
Capacity Building | 1 | 2024 | 265 | 0.190 |
Why?
|
Environmental Microbiology | 1 | 2021 | 47 | 0.190 |
Why?
|
Ciprofloxacin | 2 | 2015 | 313 | 0.190 |
Why?
|
Mammals | 2 | 2024 | 1136 | 0.190 |
Why?
|
Sequence Analysis, RNA | 3 | 2020 | 2038 | 0.180 |
Why?
|
Phylogeography | 2 | 2018 | 72 | 0.180 |
Why?
|
Liberia | 2 | 2023 | 176 | 0.180 |
Why?
|
Vesiculovirus | 1 | 2020 | 53 | 0.170 |
Why?
|
Computational Biology | 2 | 2024 | 3543 | 0.170 |
Why?
|
Laboratories, Hospital | 1 | 2021 | 192 | 0.170 |
Why?
|
Chlorpheniramine | 3 | 2008 | 13 | 0.170 |
Why?
|
Nucleic Acids | 1 | 2022 | 189 | 0.160 |
Why?
|
Sulfalene | 3 | 2008 | 3 | 0.160 |
Why?
|
Fluoroquinolones | 1 | 2021 | 309 | 0.160 |
Why?
|
Blood | 3 | 2010 | 597 | 0.160 |
Why?
|
Treatment Outcome | 24 | 2021 | 65379 | 0.160 |
Why?
|
Viral Envelope Proteins | 2 | 2020 | 641 | 0.160 |
Why?
|
Carrier Proteins | 1 | 2012 | 4936 | 0.160 |
Why?
|
Ritonavir | 1 | 2021 | 330 | 0.160 |
Why?
|
Histamine H1 Antagonists | 3 | 2008 | 101 | 0.160 |
Why?
|
Dogs | 1 | 2024 | 3846 | 0.160 |
Why?
|
Africa South of the Sahara | 5 | 2022 | 751 | 0.160 |
Why?
|
Haplorhini | 1 | 2019 | 524 | 0.150 |
Why?
|
HIV Infections | 2 | 2022 | 17575 | 0.150 |
Why?
|
Cattle | 1 | 2024 | 3826 | 0.150 |
Why?
|
Chromosome Mapping | 1 | 2006 | 4622 | 0.150 |
Why?
|
Administration, Oral | 5 | 2021 | 4039 | 0.150 |
Why?
|
Receptors, Virus | 1 | 2021 | 648 | 0.150 |
Why?
|
Plants, Medicinal | 2 | 2010 | 167 | 0.140 |
Why?
|
Escherichia coli Infections | 1 | 2021 | 524 | 0.140 |
Why?
|
Survivors | 3 | 2022 | 2382 | 0.140 |
Why?
|
Rodentia | 1 | 2018 | 262 | 0.140 |
Why?
|
Immunity, Cellular | 1 | 2022 | 1561 | 0.140 |
Why?
|
Likelihood Functions | 1 | 2020 | 993 | 0.140 |
Why?
|
Drug Resistance, Viral | 1 | 2022 | 869 | 0.130 |
Why?
|
DNA, Bacterial | 1 | 2021 | 1479 | 0.130 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2020 | 4646 | 0.130 |
Why?
|
Sesquiterpenes | 2 | 2007 | 177 | 0.130 |
Why?
|
Biological Evolution | 3 | 2016 | 1078 | 0.130 |
Why?
|
Alleles | 3 | 2012 | 6892 | 0.120 |
Why?
|
South Africa | 1 | 2021 | 1871 | 0.120 |
Why?
|
Adult | 21 | 2023 | 223640 | 0.120 |
Why?
|
Vaccines | 1 | 2024 | 842 | 0.120 |
Why?
|
Filoviridae | 1 | 2014 | 15 | 0.120 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 589 | 0.120 |
Why?
|
Markov Chains | 1 | 2018 | 977 | 0.120 |
Why?
|
Prevalence | 7 | 2022 | 15872 | 0.120 |
Why?
|
Drug Administration Schedule | 3 | 2021 | 4859 | 0.120 |
Why?
|
Young Adult | 12 | 2023 | 60049 | 0.120 |
Why?
|
Viral Vaccines | 1 | 2020 | 596 | 0.120 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 790 | 0.120 |
Why?
|
Promethazine | 3 | 2009 | 29 | 0.110 |
Why?
|
Plant Extracts | 2 | 2010 | 499 | 0.110 |
Why?
|
Inhibitory Concentration 50 | 2 | 2012 | 466 | 0.110 |
Why?
|
Clinical Laboratory Techniques | 1 | 2019 | 749 | 0.110 |
Why?
|
Health Resources | 1 | 2020 | 950 | 0.110 |
Why?
|
Databases, Nucleic Acid | 1 | 2014 | 204 | 0.110 |
Why?
|
Thiazoles | 1 | 2021 | 1542 | 0.110 |
Why?
|
Population Surveillance | 2 | 2021 | 2598 | 0.110 |
Why?
|
Mutation | 7 | 2023 | 30228 | 0.110 |
Why?
|
Antitubercular Agents | 1 | 2021 | 1391 | 0.100 |
Why?
|
DNA, Viral | 3 | 2023 | 2205 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3813 | 0.100 |
Why?
|
Aminoquinolines | 1 | 2012 | 105 | 0.100 |
Why?
|
Child Health Services | 1 | 2017 | 645 | 0.090 |
Why?
|
Genetic Testing | 1 | 2024 | 3587 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2020 | 1802 | 0.090 |
Why?
|
Body Weight | 3 | 2012 | 4629 | 0.090 |
Why?
|
Influenza, Human | 1 | 2022 | 1539 | 0.090 |
Why?
|
Public Health | 1 | 2024 | 2682 | 0.090 |
Why?
|
Bayes Theorem | 1 | 2018 | 2353 | 0.090 |
Why?
|
Genome, Human | 2 | 2014 | 4450 | 0.090 |
Why?
|
Antiviral Agents | 2 | 2021 | 3064 | 0.090 |
Why?
|
Genetic Vectors | 1 | 2020 | 3413 | 0.090 |
Why?
|
Desiccation | 1 | 2009 | 77 | 0.080 |
Why?
|
Middle Aged | 11 | 2023 | 223491 | 0.080 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 2010 | 767 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2019 | 2185 | 0.080 |
Why?
|
Medicine, Traditional | 1 | 2010 | 89 | 0.080 |
Why?
|
Specimen Handling | 2 | 2015 | 708 | 0.080 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2010 | 412 | 0.080 |
Why?
|
Membrane Proteins | 1 | 2006 | 7880 | 0.080 |
Why?
|
Acute Disease | 4 | 2018 | 7242 | 0.080 |
Why?
|
Proteins | 1 | 2004 | 6006 | 0.080 |
Why?
|
Time Factors | 7 | 2021 | 40272 | 0.080 |
Why?
|
Disease | 1 | 2014 | 673 | 0.080 |
Why?
|
Multigene Family | 1 | 2012 | 1082 | 0.080 |
Why?
|
Arm | 1 | 2011 | 590 | 0.080 |
Why?
|
Herpes Labialis | 1 | 2008 | 28 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2020 | 1943 | 0.080 |
Why?
|
Gene Dosage | 2 | 2011 | 1221 | 0.070 |
Why?
|
Blood Chemical Analysis | 1 | 2009 | 436 | 0.070 |
Why?
|
Brazil | 1 | 2012 | 1248 | 0.070 |
Why?
|
Chromatography, High Pressure Liquid | 4 | 2013 | 1539 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2015 | 10776 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 26375 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1539 | 0.070 |
Why?
|
Plasmodium | 1 | 2010 | 248 | 0.070 |
Why?
|
Base Sequence | 2 | 2015 | 12422 | 0.070 |
Why?
|
Interleukins | 1 | 2012 | 796 | 0.070 |
Why?
|
Orosomucoid | 1 | 2006 | 45 | 0.070 |
Why?
|
Follow-Up Studies | 7 | 2017 | 39407 | 0.070 |
Why?
|
Atovaquone | 1 | 2006 | 56 | 0.070 |
Why?
|
Hepatomegaly | 1 | 2006 | 84 | 0.070 |
Why?
|
Multicenter Studies as Topic | 2 | 2023 | 1727 | 0.070 |
Why?
|
Travel | 2 | 2017 | 800 | 0.070 |
Why?
|
Amino Acid Sequence | 3 | 2020 | 13423 | 0.070 |
Why?
|
Treatment Failure | 3 | 2012 | 2663 | 0.070 |
Why?
|
Quinolines | 3 | 2018 | 768 | 0.060 |
Why?
|
Rats | 1 | 2022 | 23835 | 0.060 |
Why?
|
Senegal | 1 | 2006 | 255 | 0.060 |
Why?
|
Guinea | 2 | 2016 | 33 | 0.060 |
Why?
|
Drug Monitoring | 1 | 2012 | 964 | 0.060 |
Why?
|
Age Distribution | 1 | 2011 | 2877 | 0.060 |
Why?
|
Chromatography, Liquid | 1 | 2009 | 997 | 0.060 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.060 |
Why?
|
Medicine, African Traditional | 1 | 2005 | 31 | 0.060 |
Why?
|
Databases as Topic | 1 | 2007 | 475 | 0.060 |
Why?
|
Malawi | 1 | 2006 | 309 | 0.060 |
Why?
|
Fever | 3 | 2024 | 1620 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2024 | 7463 | 0.060 |
Why?
|
Risk Factors | 6 | 2017 | 74962 | 0.060 |
Why?
|
Codon | 1 | 2006 | 599 | 0.060 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2010 | 1339 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2015 | 22296 | 0.060 |
Why?
|
Sensitivity and Specificity | 5 | 2020 | 14737 | 0.060 |
Why?
|
Seizures | 1 | 2017 | 3000 | 0.060 |
Why?
|
Genes, pol | 1 | 2023 | 52 | 0.060 |
Why?
|
Recurrence | 2 | 2008 | 8506 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6541 | 0.050 |
Why?
|
Program Evaluation | 1 | 2011 | 2505 | 0.050 |
Why?
|
DNA Copy Number Variations | 1 | 2012 | 2046 | 0.050 |
Why?
|
Microscopy | 2 | 2008 | 909 | 0.050 |
Why?
|
False Negative Reactions | 1 | 2004 | 575 | 0.050 |
Why?
|
Hepatitis B e Antigens | 1 | 2023 | 135 | 0.050 |
Why?
|
Immunoassay | 2 | 2018 | 745 | 0.050 |
Why?
|
Hepatitis B Antibodies | 1 | 2023 | 156 | 0.050 |
Why?
|
Age Factors | 5 | 2014 | 18471 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2006 | 2750 | 0.050 |
Why?
|
Herpesvirus 1, Human | 1 | 2008 | 744 | 0.050 |
Why?
|
Sequence Alignment | 1 | 2006 | 2176 | 0.050 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2023 | 294 | 0.050 |
Why?
|
Prospective Studies | 7 | 2023 | 54920 | 0.050 |
Why?
|
Genetic Loci | 1 | 2011 | 2630 | 0.050 |
Why?
|
Biodiversity | 1 | 2024 | 346 | 0.050 |
Why?
|
Ribavirin | 2 | 2014 | 395 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7955 | 0.050 |
Why?
|
Drug Interactions | 3 | 2014 | 1420 | 0.050 |
Why?
|
Genetic Markers | 1 | 2007 | 2604 | 0.050 |
Why?
|
Nitro Compounds | 1 | 2021 | 74 | 0.050 |
Why?
|
Half-Life | 2 | 2013 | 650 | 0.050 |
Why?
|
Molecular Epidemiology | 2 | 2017 | 473 | 0.050 |
Why?
|
Biomedical Research | 1 | 2016 | 3464 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10267 | 0.040 |
Why?
|
Genome-Wide Association Study | 2 | 2024 | 12778 | 0.040 |
Why?
|
Survival Analysis | 4 | 2014 | 10117 | 0.040 |
Why?
|
Hospitals, Teaching | 2 | 2017 | 1158 | 0.040 |
Why?
|
Immune Sera | 1 | 2020 | 605 | 0.040 |
Why?
|
HLA-DQ Antigens | 1 | 2020 | 190 | 0.040 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20224 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2020 | 6510 | 0.040 |
Why?
|
Hematuria | 1 | 2020 | 233 | 0.040 |
Why?
|
Attitude to Health | 1 | 2008 | 2025 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9261 | 0.040 |
Why?
|
Verapamil | 2 | 2012 | 242 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 4588 | 0.040 |
Why?
|
Congo | 1 | 2018 | 13 | 0.040 |
Why?
|
Viral Load | 2 | 2021 | 3398 | 0.040 |
Why?
|
Oligonucleotide Probes | 1 | 2019 | 417 | 0.040 |
Why?
|
Drug Repositioning | 1 | 2021 | 244 | 0.040 |
Why?
|
Culicidae | 1 | 2019 | 110 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 17626 | 0.040 |
Why?
|
Fluorescence | 1 | 2020 | 759 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2021 | 640 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15939 | 0.040 |
Why?
|
Validation Studies as Topic | 1 | 2018 | 162 | 0.040 |
Why?
|
Linear Models | 2 | 2018 | 5878 | 0.040 |
Why?
|
Biological Assay | 1 | 2020 | 627 | 0.040 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2018 | 134 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2020 | 913 | 0.040 |
Why?
|
Proteinuria | 1 | 2020 | 613 | 0.040 |
Why?
|
Serologic Tests | 1 | 2019 | 383 | 0.040 |
Why?
|
Arenavirus | 1 | 2016 | 8 | 0.030 |
Why?
|
Population Dynamics | 1 | 2018 | 314 | 0.030 |
Why?
|
Microfluidics | 1 | 2022 | 674 | 0.030 |
Why?
|
Standard of Care | 1 | 2021 | 570 | 0.030 |
Why?
|
Climate | 1 | 2017 | 147 | 0.030 |
Why?
|
Virology | 1 | 2016 | 76 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2020 | 1524 | 0.030 |
Why?
|
Immunization | 1 | 2020 | 1219 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2020 | 611 | 0.030 |
Why?
|
Gene Library | 1 | 2019 | 1061 | 0.030 |
Why?
|
Oligonucleotides | 1 | 2019 | 564 | 0.030 |
Why?
|
Species Specificity | 1 | 2020 | 2417 | 0.030 |
Why?
|
Demography | 1 | 2020 | 1642 | 0.030 |
Why?
|
Epitope Mapping | 1 | 2016 | 300 | 0.030 |
Why?
|
Geography | 1 | 2017 | 654 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2020 | 2069 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 11918 | 0.030 |
Why?
|
Antibody Specificity | 1 | 2016 | 1065 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 857 | 0.030 |
Why?
|
Exanthema | 1 | 2018 | 503 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2020 | 1374 | 0.030 |
Why?
|
Pregnancy | 3 | 2023 | 30200 | 0.030 |
Why?
|
Primate Diseases | 1 | 2012 | 15 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2018 | 1528 | 0.030 |
Why?
|
Logistic Models | 2 | 2018 | 13323 | 0.030 |
Why?
|
England | 1 | 2014 | 532 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2016 | 1682 | 0.030 |
Why?
|
Virus Diseases | 1 | 2019 | 723 | 0.030 |
Why?
|
Antigens, Bacterial | 1 | 2018 | 1150 | 0.030 |
Why?
|
Bacterial Toxins | 1 | 2018 | 923 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 2013 | 363 | 0.030 |
Why?
|
Antibodies | 1 | 2020 | 2425 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2016 | 1497 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1468 | 0.020 |
Why?
|
Internationality | 1 | 2017 | 1008 | 0.020 |
Why?
|
Genetics, Medical | 1 | 2014 | 334 | 0.020 |
Why?
|
Vomiting | 1 | 2014 | 655 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2020 | 1238 | 0.020 |
Why?
|
Health | 1 | 2014 | 399 | 0.020 |
Why?
|
Phenanthrenes | 1 | 2011 | 66 | 0.020 |
Why?
|
Incidence | 2 | 2023 | 21544 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2014 | 794 | 0.020 |
Why?
|
Hypoxanthine | 1 | 2010 | 28 | 0.020 |
Why?
|
Gestational Age | 1 | 2019 | 3615 | 0.020 |
Why?
|
Primates | 1 | 2012 | 521 | 0.020 |
Why?
|
Diamines | 1 | 2010 | 60 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3623 | 0.020 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2009 | 199 | 0.020 |
Why?
|
International Cooperation | 1 | 2016 | 1438 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10377 | 0.020 |
Why?
|
Epitopes | 1 | 2016 | 2525 | 0.020 |
Why?
|
Tritium | 1 | 2010 | 707 | 0.020 |
Why?
|
Histamine Antagonists | 1 | 2009 | 94 | 0.020 |
Why?
|
Erythrocytes, Abnormal | 2 | 1960 | 121 | 0.020 |
Why?
|
Sickle Cell Trait | 2 | 1960 | 86 | 0.020 |
Why?
|
Organic Chemicals | 1 | 2010 | 211 | 0.020 |
Why?
|
Benzothiazoles | 1 | 2010 | 248 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2021 | 81801 | 0.020 |
Why?
|
Community Medicine | 1 | 2008 | 23 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2537 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2019 | 2961 | 0.020 |
Why?
|
Reference Standards | 1 | 2012 | 1013 | 0.020 |
Why?
|
Viral Proteins | 1 | 2015 | 1802 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2014 | 1070 | 0.020 |
Why?
|
Patient Compliance | 2 | 2008 | 2693 | 0.020 |
Why?
|
Seasons | 1 | 2014 | 1526 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 41795 | 0.020 |
Why?
|
Diarrhea | 1 | 2014 | 1320 | 0.020 |
Why?
|
Common Cold | 1 | 2008 | 63 | 0.020 |
Why?
|
Glycoproteins | 1 | 2015 | 2204 | 0.020 |
Why?
|
Life Cycle Stages | 1 | 2008 | 161 | 0.020 |
Why?
|
Rural Population | 2 | 2008 | 2318 | 0.020 |
Why?
|
Community Health Services | 1 | 2012 | 659 | 0.020 |
Why?
|
Suppositories | 1 | 2007 | 16 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8731 | 0.020 |
Why?
|
Desipramine | 1 | 2006 | 183 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8562 | 0.020 |
Why?
|
Artemia | 1 | 2005 | 6 | 0.020 |
Why?
|
Government Programs | 1 | 2008 | 278 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5404 | 0.020 |
Why?
|
Lethal Dose 50 | 1 | 2005 | 71 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2010 | 1081 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10654 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2007 | 556 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9682 | 0.020 |
Why?
|
Sentinel Surveillance | 1 | 2007 | 292 | 0.020 |
Why?
|
Methanol | 1 | 2005 | 91 | 0.020 |
Why?
|
Toxicity Tests | 1 | 2005 | 114 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15455 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12092 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 2006 | 692 | 0.010 |
Why?
|
Mortality | 1 | 2014 | 2917 | 0.010 |
Why?
|
Drug Synergism | 1 | 2007 | 1762 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5512 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2011 | 6241 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2009 | 8051 | 0.010 |
Why?
|
Mice | 3 | 2015 | 82017 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13646 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5375 | 0.010 |
Why?
|
Focus Groups | 1 | 2008 | 1453 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2742 | 0.010 |
Why?
|
Filariasis | 1 | 1961 | 26 | 0.010 |
Why?
|
Health Education | 1 | 2008 | 1057 | 0.010 |
Why?
|
Anemia, Sickle Cell | 2 | 1960 | 1065 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2008 | 2740 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26411 | 0.010 |
Why?
|
Cameroon | 4 | 1961 | 79 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5792 | 0.010 |
Why?
|
Leishmaniasis | 1 | 1960 | 67 | 0.010 |
Why?
|
Ulcer | 1 | 1960 | 203 | 0.010 |
Why?
|
Gene Expression | 1 | 2011 | 7598 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2008 | 2240 | 0.010 |
Why?
|
Blood Group Antigens | 1 | 1959 | 185 | 0.010 |
Why?
|
Regression Analysis | 1 | 2007 | 6350 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5313 | 0.010 |
Why?
|
Qualitative Research | 1 | 2008 | 3131 | 0.010 |
Why?
|
Aged | 2 | 2021 | 171562 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3722 | 0.010 |
Why?
|
Caregivers | 1 | 2008 | 2303 | 0.010 |
Why?
|
Internet | 1 | 2007 | 3107 | 0.010 |
Why?
|
Survival Rate | 1 | 2008 | 12870 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18362 | 0.010 |
Why?
|
Research | 1 | 1959 | 1981 | 0.010 |
Why?
|
United States | 1 | 2014 | 73150 | 0.000 |
Why?
|